B complex infusions are generally considered safe, but there may be some risks and side effects, including: Reactions at the site of intravenous catheter insertion, such as inflammation, pain or infection
GI effects are the primary concern, primarily nausea, vomiting, diarrhea, and constipation
nearly every day
The fundamental difference is that GLP-1 agonists eliminate hunger and create a state of pharmaceutical appetite suppression, while AOD-9604 leaves appetite entirely unchanged
given subcutaneously the apparent half-life is substantially longer, in the region of a day
Published research The studies The evidence, study by study